Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Manufacturing method of semiconductor device
Checking an ESD behavior of integrated circuits on the circuit level
Vehicle member and process for producing the same
Methods for detection of cardiac rhythm disorders using basket style cardiac mapping catheter
Shaft positioning device
Self-described rendering of data
Method and system for an adaptive channel grid of an optical network
  Randomly Featured Patents
Sheath for tissue spectroscopy
Hazardous substance removing method, hazardous substance removing material used therein such as air filter, mask, wipe sheet, and the like, and storage method thereof
Device for use in preparing varied layered drinks
Methods of infrared visualization of air flow
Process for producing chrome leather
Pressure activated flow path seal for a steam turbine
Methods for reducing artifacts in near-to-eye display systems
High vacuum freeze-drying
Customization of search results for search queries received from third party sites
Apparatus method and system for peripheral component interconnect bus using accelerated graphics port logic circuits